VIRACTA THERAPEUTICS INC's ticker is VIRX and the CUSIP is 92765F108. A total of 70 filers reported holding VIRACTA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.31 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,583,093 | -26.4% | 1,522,204 | -0.2% | 0.00% | – |
| Q2 2023 | $2,150,028 | -13.3% | 1,524,843 | -2.2% | 0.00% | -100.0% |
| Q1 2023 | $2,480,119 | +7.5% | 1,559,823 | -1.3% | 0.00% | 0.0% |
| Q4 2022 | $2,306,535 | -67.3% | 1,579,819 | -4.5% | 0.00% | -50.0% |
| Q3 2022 | $7,064,000 | +8.9% | 1,654,155 | -1.1% | 0.00% | 0.0% |
| Q2 2022 | $6,488,000 | -19.8% | 1,672,162 | -1.6% | 0.00% | 0.0% |
| Q1 2022 | $8,087,000 | +40.7% | 1,698,854 | +7.9% | 0.00% | +100.0% |
| Q4 2021 | $5,748,000 | -54.5% | 1,574,601 | -0.1% | 0.00% | -66.7% |
| Q3 2021 | $12,646,000 | -29.2% | 1,576,846 | +0.1% | 0.00% | -25.0% |
| Q2 2021 | $17,862,000 | +23.2% | 1,575,174 | +0.5% | 0.00% | +33.3% |
| Q1 2021 | $14,496,000 | – | 1,567,082 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 831,625 | $7,693,000 | 1.42% |
| BVF INC/IL | 3,094,174 | $28,621,000 | 1.07% |
| SECTORAL ASSET MANAGEMENT INC | 647,556 | $5,990,000 | 0.45% |
| Logos Global Management LP | 470,000 | $4,348,000 | 0.42% |
| AlphaCentric Advisors LLC | 92,402 | $855,000 | 0.29% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 28,570 | $264,000 | 0.14% |
| Opaleye Management Inc. | 103,600 | $958,000 | 0.14% |
| Monashee Investment Management LLC | 84,802 | $784,000 | 0.12% |
| KETTLE HILL CAPITAL MANAGEMENT, LLC | 93,900 | $869,000 | 0.08% |
| Ikarian Capital, LLC | 155,599 | $1,439,000 | 0.05% |